R 753 (Glyburide and metformin hydrochloride 5 mg / 500 mg)

Pill imprint R 753 has been identified as Glyburide and metformin hydrochloride 5 mg / 500 mg.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 5 mg / 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for R 753

Glyburide and metformin hydrochloride 5 mg / 500 mg R 753
Glyburide and metformin hydrochloride 5 mg / 500 mg R 753  Front
Glyburide and metformin hydrochloride 5 mg / 500 mg R 753  Back
Glyburide and metformin hydrochloride 5 mg / 500 mg R 753
Glyburide and metformin hydrochloride
Imprint:
R 753
Strength:
5 mg / 500 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis Inc.
National Drug Code (NDC):
45963-0753
Inactive Ingredients:
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium hydroxide
sorbic acid
titanium dioxide
triacetin
FD&C Blue No. 2
FD&C Yellow No. 6
methacrylic acid - methyl methacrylate copolymer (1:2)

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)